{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T11:32:38Z","timestamp":1768044758756,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,9]]},"DOI":"10.7759\/cureus.101207","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:36:38Z","timestamp":1768030598000},"source":"Crossref","is-referenced-by-count":0,"title":["Undifferentiated Nasopharyngeal Carcinoma in Low- and Middle-Income Countries: Clinical, Molecular, and Health-System-Related Challenges"],"prefix":"10.7759","author":[{"given":"Rim","family":"Alami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reyzane","family":"El Mjabber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reda","family":"Alami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmaa","family":"Naim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2016.01.040","article-title":"Global trends in incidence and mortality of nasopharyngeal carcinoma","volume":"374","author":"Tang LL","year":"2016","unstructured":"Tang LL, Chen WQ, Xue WQ, He YQ, Zheng RS, Zeng YX, Jia WH. Global trends in incidence and mortality of nasopharyngeal carcinoma. Cancer Lett. 2016, 374:22-30. 10.1016\/j.canlet.2016.01.040","journal-title":"Cancer Lett"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-021-06922-2","article-title":"The global burden of nasopharyngeal carcinoma from 2009 to 2019: an observational study based on the Global Burden of Disease Study 2019","volume":"279","author":"Yu H","year":"2022","unstructured":"Yu H, Yin X, Mao Y, Chen M, Tang Q, Yan S. The global burden of nasopharyngeal carcinoma from 2009 to 2019: an observational study based on the Global Burden of Disease Study 2019. Eur Arch Otorhinolaryngol. 2022, 279:1519-33. 10.1007\/s00405-021-06922-2","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-06-0353","article-title":"The enigmatic epidemiology of nasopharyngeal carcinoma","volume":"15","author":"Chang ET","year":"2006","unstructured":"Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006, 15:1765-77. 10.1158\/1055-9965.EPI-06-0353","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-20-1702","article-title":"The evolving epidemiology of nasopharyngeal carcinoma","volume":"30","author":"Chang ET","year":"2021","unstructured":"Chang ET, Ye W, Zeng YX, Adami HO. The evolving epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2021, 30:1035-47. 10.1158\/1055-9965.EPI-20-1702","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2196\/49968","article-title":"Nasopharyngeal cancer incidence and mortality in 185 countries in 2020 and the projected burden in 2040: population-based global epidemiological profiling","volume":"9","author":"Zhang Y","year":"2023","unstructured":"Zhang Y, Rumgay H, Li M, Cao S, Chen W. Nasopharyngeal cancer incidence and mortality in 185 countries in 2020 and the projected burden in 2040: population-based global epidemiological profiling. JMIR Public Health Surveill. 2023, 9:e49968. 10.2196\/49968","journal-title":"JMIR Public Health Surveill"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JGO.17.00175","article-title":"Estimates of cancer incidence in Ethiopia in 2015 using population-based registry data","volume":"4","author":"Memirie ST","year":"2018","unstructured":"Memirie ST, Habtemariam MK, Asefa M, et al.. Estimates of cancer incidence in Ethiopia in 2015 using population-based registry data. J Glob Oncol. 2018, 4:1-11. 10.1200\/JGO.17.00175","journal-title":"J Glob Oncol"},{"key":"ref8","article-title":"Cancer Incidence in Five Continents - Volume XII","author":"International Agency for Research on Cancer","year":"2025","unstructured":"International Agency for Research on Cancer. Cancer Incidence in Five Continents - Volume XII. IARC Scientific Publications, Lyon, France; 2025. https:\/\/www.iarc.who.int\/news-events\/cancer-incidence-in-five-continents-volume-xii-now-available-in-print-format\/."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-007-0012-7","article-title":"Update on nasopharyngeal carcinoma","volume":"1","author":"Thompson LD","year":"2007","unstructured":"Thompson LD. Update on nasopharyngeal carcinoma. Head Neck Pathol. 2007, 1:81-6. 10.1007\/s12105-007-0012-7","journal-title":"Head Neck Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.60.9347","article-title":"Management of nasopharyngeal carcinoma: current practice and future perspective","volume":"33","author":"Lee AW","year":"2015","unstructured":"Lee AW, Ma BB, Ng WT, Chan AT. Management of nasopharyngeal carcinoma: current practice and future perspective. J Clin Oncol. 2015, 33:3356-64. 10.1200\/JCO.2015.60.9347","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol29090475","article-title":"Nasopharyngeal carcinoma progression: accumulating genomic instability and persistent Epstein-Barr virus infection","volume":"29","author":"Liu X","year":"2022","unstructured":"Liu X, Deng Y, Huang Y, et al.. Nasopharyngeal carcinoma progression: accumulating genomic instability and persistent Epstein-Barr virus infection. Curr Oncol. 2022, 29:6035-52. 10.3390\/curroncol29090475","journal-title":"Curr Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2023.100567","article-title":"Proteomics profiling reveals the molecular signatures and potential therapeutic targets of human nasopharyngeal carcinoma","volume":"22","author":"Fu Y","year":"2023","unstructured":"Fu Y, Liang X, Yang X, et al.. Proteomics profiling reveals the molecular signatures and potential therapeutic targets of human nasopharyngeal carcinoma. Mol Cell Proteomics. 2023, 22:100567. 10.1016\/j.mcpro.2023.100567","journal-title":"Mol Cell Proteomics"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s1044579x02000913","article-title":"Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma","volume":"12","author":"Chan KC","year":"2002","unstructured":"Chan KC, Lo YM. Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma. Semin Cancer Biol. 2002, 12:489-96. 10.1016\/s1044579x02000913","journal-title":"Semin Cancer Biol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000845","article-title":"The clinical utility of plasma Epstein-Barr virus DNA assays in nasopharyngeal carcinoma: the dawn of a new era?: a systematic review and meta-analysis of 7836 cases","volume":"94","author":"Zhang W","year":"2015","unstructured":"Zhang W, Chen Y, Chen L, et al.. The clinical utility of plasma Epstein-Barr virus DNA assays in nasopharyngeal carcinoma: the dawn of a new era?: a systematic review and meta-analysis of 7836 cases. Medicine (Baltimore). 2015, 94:e845. 10.1097\/MD.0000000000000845","journal-title":"Medicine (Baltimore)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6754","article-title":"Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy","volume":"7","author":"Zhang L","year":"2016","unstructured":"Zhang L, Tang LQ, Chen QY, et al.. Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy. Oncotarget. 2016, 7:6221-30. 10.18632\/oncotarget.6754","journal-title":"Oncotarget"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5732\/cjc.014.10192","article-title":"Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma","volume":"33","author":"Chan KC","year":"2014","unstructured":"Chan KC. Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma. Chin J Cancer. 2014, 33:598-603. 10.5732\/cjc.014.10192","journal-title":"Chin J Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-208","article-title":"Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a Western population","volume":"12","author":"Ferrari D","year":"2012","unstructured":"Ferrari D, Codec\u00e0 C, Bertuzzi C, et al.. Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a Western population. BMC Cancer. 2012, 12:208. 10.1186\/1471-2407-12-208","journal-title":"BMC Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.105128","article-title":"The appropriate use of circulating EBV-DNA in nasopharyngeal carcinoma: comprehensive clinical practice guidelines evaluation","volume":"114","author":"Trevisiol C","year":"2021","unstructured":"Trevisiol C, Gion M, Vaona A, et al.. The appropriate use of circulating EBV-DNA in nasopharyngeal carcinoma: comprehensive clinical practice guidelines evaluation. Oral Oncol. 2021, 114:105128. 10.1016\/j.oraloncology.2020.105128","journal-title":"Oral Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2478\/raon-2018-0016","article-title":"Prognostic value of plasma EBV DNA for nasopharyngeal cancer patients during treatment with intensity-modulated radiation therapy and concurrent chemotherapy","volume":"52","author":"Lertbutsayanukul C","year":"2018","unstructured":"Lertbutsayanukul C, Kannarunimit D, Prayongrat A, Chakkabat C, Kitpanit S, Hansasuta P. Prognostic value of plasma EBV DNA for nasopharyngeal cancer patients during treatment with intensity-modulated radiation therapy and concurrent chemotherapy. Radiol Oncol. 2018, 52:195-203. 10.2478\/raon-2018-0016","journal-title":"Radiol Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2013.10.020","article-title":"Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities","volume":"110","author":"Sun X","year":"2014","unstructured":"Sun X, Su S, Chen C, et al.. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol. 2014, 110:398-403. 10.1016\/j.radonc.2013.10.020","journal-title":"Radiother Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70126-9","article-title":"Chemotherapy and radiotherapy in NPC: an update of the MAC-NPC meta-analysis","volume":"16","author":"Blanchard P","year":"2015","unstructured":"Blanchard P, Lee A, Marguet S, et al.. Chemotherapy and radiotherapy in NPC: an update of the MAC-NPC meta-analysis. Lancet Oncol. 2015, 16:645-55. 10.1016\/S1470-2045(15)70126-9","journal-title":"Lancet Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1905287","article-title":"Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma","volume":"381","author":"Zhang Y","year":"2019","unstructured":"Zhang Y, Chen L, Hu GQ, et al.. Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma. N Engl J Med. 2019, 381:1124-35. 10.1056\/NEJMoa1905287","journal-title":"N Engl J Med"},{"key":"ref23","unstructured":"The IAEA Directory of Radiotherapy Centres (DIRAC). (2015). Accessed. December 20, 2025: http:\/\/https:\/dirac.iaea.org\/."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70532-6","article-title":"Status of radiotherapy resources in Africa: an International Atomic Energy Agency analysis","volume":"14","author":"Abdel-Wahab M","year":"2013","unstructured":"Abdel-Wahab M, Bourque JM, Pynda Y, I\u017cewska J, Van der Merwe D, Zubizarreta E, Rosenblatt E. Status of radiotherapy resources in Africa: an International Atomic Energy Agency analysis. Lancet Oncol. 2013, 14:168-75. 10.1016\/S1470-2045(12)70532-6","journal-title":"Lancet Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13285","article-title":"Nasopharyngeal carcinoma: profile, challenges and 5-year outcome in a Nigerian tertiary hospital","volume":"8","author":"Eniola EJA","year":"2017","unstructured":"Eniola EJA, Bola AY, Pelumi OP, Dubem U, Mike I, Babatunde O. Nasopharyngeal carcinoma: profile, challenges and 5-year outcome in a Nigerian tertiary hospital. Oncotarget. 2017, 8:14078-88. 10.18632\/oncotarget.13285","journal-title":"Oncotarget"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-021-00353-8","article-title":"Circulating cell-free Epstein-Barr virus DNA levels and clinical features in Moroccan patients with nasopharyngeal carcinoma","volume":"16","author":"Gihbid A","year":"2021","unstructured":"Gihbid A, Benzeid R, Faouzi A, et al.. Circulating cell-free Epstein-Barr virus DNA levels and clinical features in Moroccan patients with nasopharyngeal carcinoma. Infect Agent Cancer. 2021, 16:15. 10.1186\/s13027-021-00353-8","journal-title":"Infect Agent Cancer"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-015-0119-8","article-title":"Detection of nasopharyngeal carcinoma in Morocco (North Africa) using a multiplex methylation-specific PCR biomarker assay","volume":"7","author":"Nawaz I","year":"2015","unstructured":"Nawaz I, Moumad K, Martorelli D, et al.. Detection of nasopharyngeal carcinoma in Morocco (North Africa) using a multiplex methylation-specific PCR biomarker assay. Clin Epigenetics. 2015, 7:89. 10.1186\/s13148-015-0119-8","journal-title":"Clin Epigenetics"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16193282","article-title":"A proteomic analysis of nasopharyngeal carcinoma in a Moroccan subpopulation","volume":"16","author":"Reffai A","year":"2024","unstructured":"Reffai A, Hori M, Adusumilli R, et al.. A proteomic analysis of nasopharyngeal carcinoma in a Moroccan subpopulation. Cancers (Basel). 2024, 16:14-6. 10.3390\/cancers16193282","journal-title":"Cancers (Basel)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20099","article-title":"Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A\/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma","volume":"100","author":"Shao JY","year":"2004","unstructured":"Shao JY, Li YH, Gao HY, et al.. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A\/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Cancer. 2004, 100:1162-70. 10.1002\/cncr.20099","journal-title":"Cancer"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02344.x","article-title":"Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies","volume":"111","author":"Lei KI","year":"2000","unstructured":"Lei KI, Chan LY, Chan WY, Johnson PJ, Lo YM. Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies. Br J Haematol. 2000, 111:239-46. 10.1046\/j.1365-2141.2000.02344.x","journal-title":"Br J Haematol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2024.101060","article-title":"Association between time from diagnosis to treatment and survival of patients with nasopharyngeal carcinoma: a population-based cohort study","volume":"48","author":"Wei X","year":"2024","unstructured":"Wei X, Yu S, Wang J, Xiang Z, Liu L, Min Y. Association between time from diagnosis to treatment and survival of patients with nasopharyngeal carcinoma: a population-based cohort study. Curr Probl Cancer. 2024, 48:101060. 10.1016\/j.currproblcancer.2024.101060","journal-title":"Curr Probl Cancer"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.68","article-title":"The Aarhus statement: improving design and reporting of studies on early cancer diagnosis","volume":"106","author":"Weller D","year":"2012","unstructured":"Weller D, Vedsted P, Rubin G, et al.. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer. 2012, 106:1262-7. 10.1038\/bjc.2012.68","journal-title":"Br J Cancer"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-04837-5","article-title":"Psychosocial distress in cancer patients undergoing radiotherapy: a prospective national cohort of 1042 patients in Germany","volume":"149","author":"Fabian A","year":"2023","unstructured":"Fabian A, R\u00fchle A, Domschikowski J, et al.. Psychosocial distress in cancer patients undergoing radiotherapy: a prospective national cohort of 1042 patients in Germany. J Cancer Res Clin Oncol. 2023, 149:9017-24. 10.1007\/s00432-023-04837-5","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1080\/13548506.2014.967703","article-title":"Sleep characteristics and psychological symptoms in patients with locally advanced nasopharyngeal carcinoma before and after intensity-modulated radiotherapy and concurrent chemotherapy","volume":"20","author":"Qin L","year":"2015","unstructured":"Qin L, Mo YL, Li L, Wei ZJ, Zhu XD, Yin X, Wei Q. Sleep characteristics and psychological symptoms in patients with locally advanced nasopharyngeal carcinoma before and after intensity-modulated radiotherapy and concurrent chemotherapy. Psychol Health Med. 2015, 20:662-9. 10.1080\/13548506.2014.967703","journal-title":"Psychol Health Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3747\/co.22.2323","article-title":"Quality of life of nasopharyngeal cancer survivors in China","volume":"22","author":"Hong JS","year":"2015","unstructured":"Hong JS, Tian J, Han QF, Ni QY. Quality of life of nasopharyngeal cancer survivors in China. Curr Oncol. 2015, 22:e142-7. 10.3747\/co.22.2323","journal-title":"Curr Oncol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1080\/13548506.2016.1220600","article-title":"Psychological distress and coping in nasopharyngeal cancer: an explorative study in Western Europe","volume":"22","author":"Ghiggia A","year":"2017","unstructured":"Ghiggia A, Castelli L, Riva G, et al.. Psychological distress and coping in nasopharyngeal cancer: an explorative study in Western Europe. Psychol Health Med. 2017, 22:449-61. 10.1080\/13548506.2016.1220600","journal-title":"Psychol Health Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3625302","article-title":"Correlation between psychosocial distress and quality of life in patients with nasopharyngeal carcinoma following radiotherapy","volume":"2018","author":"Wang X","year":"2018","unstructured":"Wang X, Lv Y, Li W, et al.. Correlation between psychosocial distress and quality of life in patients with nasopharyngeal carcinoma following radiotherapy. J Oncol. 2018, 2018:3625302. 10.1155\/2018\/3625302","journal-title":"J Oncol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036529","article-title":"Psychological disorders, cognitive dysfunction and quality of life in nasopharyngeal carcinoma patients with radiation-induced brain injury","volume":"7","author":"Tang Y","year":"2012","unstructured":"Tang Y, Luo D, Rong X, Shi X, Peng Y. Psychological disorders, cognitive dysfunction and quality of life in nasopharyngeal carcinoma patients with radiation-induced brain injury. PLoS One. 2012, 7:e36529. 10.1371\/journal.pone.0036529","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-023-01371-8","article-title":"Remote assessment of cognition and quality of life following radiotherapy for nasopharyngeal carcinoma: deep-learning-based predictive models and MRI correlates","volume":"18","author":"Voon NS","year":"2024","unstructured":"Voon NS, Manan HA, Yahya N. Remote assessment of cognition and quality of life following radiotherapy for nasopharyngeal carcinoma: deep-learning-based predictive models and MRI correlates. J Cancer Surviv. 2024, 18:1297-308. 10.1007\/s11764-023-01371-8","journal-title":"J Cancer Surviv"},{"key":"ref40","unstructured":"World Health Organization. Promoting cancer early diagnosis. WHO activities and guidance. (2025). Accessed: December 26, 2025: https:\/\/www.who.int\/activities\/promoting-cancer-early-diagnosis."},{"key":"ref41","unstructured":"World Health Organization. Assessing national capacity for the prevention and control of noncommunicable diseases. report of the 2021 global survey. Geneva: World Health Organization; 2023. (2023). Accessed: December 26, 2025: https:\/\/www.who.int\/publications\/i\/item\/9789240071698."},{"key":"ref42","unstructured":"International Atomic Energy Agency. Planning national radiotherapy services. a practical tool. Vienna: International Atomic Energy Agency. (2020). Accessed: December 26, 2025: https:\/\/www.iaea.org\/publications\/14791\/planning-national-radiotherapy-services-a-practical-tool."},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00135-X","article-title":"Improving the quality and coverage of cancer registries globally","volume":"386","author":"Bray F","year":"2015","unstructured":"Bray F, Soerjomataram I, Mery L, Ferlay J. Improving the quality and coverage of cancer registries globally. Lancet. 2015, 386:1035-6. 10.1016\/S0140-6736(15)00135-X","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/453205-undifferentiated-nasopharyngeal-carcinoma-in-low--and-middle-income-countries-clinical-molecular-and-health-system-related-challenges","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:36:39Z","timestamp":1768030599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/453205-undifferentiated-nasopharyngeal-carcinoma-in-low--and-middle-income-countries-clinical-molecular-and-health-system-related-challenges"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":43,"URL":"https:\/\/doi.org\/10.7759\/cureus.101207","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,9]]}}}